Dermatological aspects of medicine: highly active antiretroviral therapy and the treatment of human immunodeficiency virus

被引：3
|
作者：
Finucane, K. A. [1 ]
Archer, C. B. [1 ]
机构：
[1] Univ Hosp Bristol NHS Fdn Trust, Bristol Dermatol Ctr, Bristol, Avon, England
来源：
CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2010年 / 35卷 / 01期
关键词：
D O I：
10.1111/j.1365-2230.2009.03526.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
This is the sixth in a series of CPD articles aimed at reviewing the recent general medical literature relating to topics that may be of interest to dermatologists. In this issue the new classes of anti-retroviral drugs will be described in the context of the replication cycle of human immunodeficiency virus (HIV). The regimens of drug treatments and the more common side-effects including HIV-lipodystrophy syndrome will be discussed along with the recommendations for testing of people for HIV from new guidelines.
引用
收藏
页码：107 / 109
页数：3
相关论文
共 50 条
  • [1] Highly active antiretroviral therapy and human immunodeficiency virus encephalitis
    Cook, JE
    Dasgupta, S
    Middaugh, LD
    Terry, EC
    Gorry, PR
    Wesselingh, SL
    Tyor, WR
    ANNALS OF NEUROLOGY, 2005, 57 (06) : 795 - 803
  • [2] Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1
    Shafer, RW
    Vuitton, DA
    BIOMEDICINE & PHARMACOTHERAPY, 1999, 53 (02) : 73 - 86
  • [3] Anemia and human immunodeficiency virus disease in the era of highly active antiretroviral therapy
    Moore, RD
    SEMINARS IN HEMATOLOGY, 2000, 37 (04) : 18 - 23
  • [4] Severe hypertriglyceridaemia associated with human immunodeficiency virus and highly active antiretroviral therapy
    Carling, RS
    Hextall, R
    DeSilva, PA
    Barth, JH
    ANNALS OF CLINICAL BIOCHEMISTRY, 2002, 39 : 409 - 413
  • [5] Highly Active Antiretroviral Therapy-Associated Ptosis in Patients With Human Immunodeficiency Virus
    Silkiss, Rona Z.
    Lee, Han
    Ray, Vincent L. Gills
    ARCHIVES OF OPHTHALMOLOGY, 2009, 127 (03) : 345 - 346
  • [6] Lipodystrophy in Human Immunodeficiency Virus (HIV) Patients on Highly Active Antiretroviral Therapy (HAART)
    Kumar, N. Sum
    Shashibhushan, J.
    Malappa
    Venugopal, K.
    Vishwanatha, Hugo
    Menon, Mahesh
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2015, 9 (07) : 5 - 8
  • [7] Ophthalmic Manifestations of Human Immunodeficiency Virus Infection in the Era of Highly Active Antiretroviral Therapy
    Sorenson, Rebecca L.
    Jeng, Bennie H.
    ARCHIVES OF OPHTHALMOLOGY, 2012, 130 (12) : 1621 - 1623
  • [8] Lupus anticoagulant in human immunodeficiency virus -infected patients on highly active antiretroviral therapy
    Awodu, Omolade A.
    Olayemi, Edeghonghon E.
    Bazuaye, Godwin N.
    Onunu, Abel N.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2010, 53 (01) : 47 - 49
  • [9] The pathology induced by highly active antiretroviral therapy against human immunodeficiency virus: an update
    Hofman, Paul
    Nelson, Ann Marie
    CURRENT MEDICINAL CHEMISTRY, 2006, 13 (26) : 3121 - 3132
  • [10] Prevalence of Nephrolithiasis in Human Immunodeficiency Virus Infected Patients on the Highly Active Antiretroviral Therapy
    Raheem, Omer A.
    Mirheydar, Hossein S.
    Palazzi, Kerrin
    Chenoweth, Marianne
    Lakin, Charles
    Sur, Roger L.
    JOURNAL OF ENDOUROLOGY, 2012, 26 (08) : 1095 - 1098
12345